SCHEMBL757569

SCHEMBL757569

C1=CC2=Cc3ccccc3COC2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11810865 0.76 ABCG2 (0.34)
SCHEMBL5342826 0.76 P2RY6 (0.33)
SCHEMBL6302024 0.70 KDM1A (0.36)
SCHEMBL8909200 0.70
SCHEMBL11458282 0.69 PARP1 (0.36)
SCHEMBL342296 0.68 ANPEP (0.38)
SCHEMBL3889560 0.67
SCHEMBL11161414 0.65
SCHEMBL6559581 0.65
SCHEMBL4891883 0.63 OXTR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3160948-B1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2018-10-24 EP disclosed
US-10017502-B2 Benzoxazinone amides as mineralocorticoid receptor modulators ASTRAZENECA AB (SE) 2018-07-10 US disclosed
US-20170217945-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2017-08-03 US disclosed
EP-3160948-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS Astrazeneca AB (SE) 2017-05-03 EP disclosed
US-9394291-B2 Benzoxazinone amides as mineralocorticoid receptor modulators ASTRAZENECA AB (SE) 2016-07-19 US disclosed
WO-2016001631-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2016-01-07 WO disclosed
US-20150376170-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2015-12-31 US disclosed
US-8410166-B2 Fused bicyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-04-02 US disclosed
US-20130029979-A1 FUSED BICYCLIC COMPOUND TAKAHASHI YOICHI (JP) 2013-01-31 US disclosed
EP-2537845-A1 6H-dibenzo[B,E]oxepine derived nonsteroidal mineralocorticoid receptor antagonists Eli Lilly and Company (US) 2012-12-26 EP disclosed
US-8258131-B2 Fused bicyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-09-04 US disclosed
US-8188073-B2 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
EP-1984345-B9 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-21 EP disclosed
US-20110251185-A1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS IIJIMA TORU 2011-10-13 US disclosed
EP-1984345-B1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2011-08-31 EP disclosed
US-7998956-B2 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-08-16 US disclosed
US-20100204218-A1 FUSED BICYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-08-12 US disclosed
US-20090023716-A1 Benzoxazines and Related Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid Receptor Modulating Agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-01-22 US disclosed
EP-1984345-A1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS Mitsubishi Tanabe Pharma Corporation (JP) 2008-10-29 EP disclosed
WO-2007089034-A1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-08-09 WO disclosed